Platelet-rich plasma (Abbreviation: PRP) is blood plasma that has been enriched with platelets. As a concentrated source of autologous platelets, PRP contains (and releases through degranulation) several different growth factors and other cytokines that stimulate healing of bone and soft tissue.
PRP is a revolutionary method that represents the new frontier for therapeutic cell regeneration, a safe and effective solution that ensures reproducibility and standardization of results.
DPGPRP is a product of new generation, made according to advanced technology, intended to improve the quality and effectiveness of their use. They are all CE‐marked (93/42/EEC updated by Directive 2007/47/CEE) and further validated in accordance with numerous ISO certifications, such as ISO 9001:2008, EN ISO 13485:2012 and EN ISO14971 : 2009, ISO 10993‐1:2009, ISO 10993‐3:2005 and FDA.
The kits are sterile primary packaging and their packaging is done in an environment with laminar flow, and are certified as a medical device class IIb, registered with the classification CND at the Ministry of Health in the National registration number.